share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga ·  Jun 10 20:06

Gainers

  • Calidi Biotherapeutics (AMEX:CLDI) shares rose 29.7% to $0.25 during Monday's pre-market session. The market value of their outstanding shares is at $16.0 million.
  • Entero Therapeutics (NASDAQ:ENTO) shares rose 22.41% to $2.99. The company's market cap stands at $8.2 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) stock increased by 19.09% to $1.31. The company's market cap stands at $8.6 million.
  • Brainstorm Cell (NASDAQ:BCLI) shares moved upwards by 15.3% to $0.47. The market value of their outstanding shares is at $33.2 million.
  • CERo Therapeutics Hldgs (NASDAQ:CERO) shares moved upwards by 15.12% to $0.78. The company's market cap stands at $11.6 million.
  • Co-Diagnostics (NASDAQ:CODX) stock moved upwards by 14.07% to $1.54. The company's market cap stands at $48.1 million.

Losers

  • Sunshine Biopharma (NASDAQ:SBFM) stock fell 36.3% to $0.36 during Monday's pre-market session. The market value of their outstanding shares is at $6.7 million.
  • Skye Bioscience (NASDAQ:SKYE) shares fell 29.62% to $7.7. The market value of their outstanding shares is at $216.1 million.
  • CNS Pharma (NASDAQ:CNSP) stock decreased by 20.8% to $4.0. The company's market cap stands at $1.3 million.
  • ARCA biopharma (NASDAQ:ABIO) shares decreased by 14.03% to $2.82. The market value of their outstanding shares is at $40.9 million.
  • BioCardia (NASDAQ:BCDA) stock declined by 13.45% to $3.22. The market value of their outstanding shares is at $5.8 million.
  • Venus Concept (NASDAQ:VERO) stock fell 13.24% to $0.81. The company's market cap stands at $5.1 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment